Sienna Cancer Diagnostics IPO

Sienna Cancer Diagnostics have come up with a breakthrough method for detecting early stage bladder cancer

They are an established Biotech ready to expand globally

  1. Already on target to turn a profit
  2. Regulatory approval in the USA, EUR & AUS
  3. 100% rebatable in the USA

If you're interested in getting involved, download a prospectus and submit an application. Ensure you enter 'OZFIN' as the Adviser/Broker code to get the best chance of receiving your allocation

If you have any questions, please call (03) 8080 5788 or email

Financial News Network (FNN) Interview with Sienna CEO Matthew Hoskin

Sienna Diagnostics IPO - Investor Presentation

* Required